Helveteq, a Swiss issuer of ESG-transparent investment products, is launching a pioneering and unique solution for ecological and sustainable investments in gold. The company has issued and listed a new exchange traded product (ETP) on SIX Swiss Exchange allowing investors to make ecological and sustainable investments in physical gold. The Swiss Green Gold ETP constitutes […]
Orascom Development Holding announced rights offering to finance current development projects. Following this, Niederer Kraft Frey advised Swiss Finance & Property as sole lead manager and Helvetische Bank as settlement agent in this Orascom’s
Orascom Development Holding successfully completed a capital increase in the amount of CHF 135 million. The transaction consisted of
Niederer Kraft Frey advised the underwriting syndicate led by Huatai Financial Holdings on the offering of global depositary receipts (GDRs) and SIX Swiss Exchange listing of Zheijang Supcon Technology under the China-Switzerland Stock Connect. Including
Walder Wyss advises Swiss biotech Alentis Therapeutics in connection with their USD 105m Series C funding to support the development of its lead assets. The funding round was led by Jeito Capital together with Novo
Zürcher Kantonalbank (‘ZKB’) priced its inaugural CHF 425 m Bail-in Bond issuance. ZKB’s Bail-in Bonds are novel instruments which have been designed and issued on the basis of a new legal framework allowing Cantonal
BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5
Bachem Holding successfully placed newly issued shares raising gross proceeds of approximately CHF 584 million by way of an accelerated bookbuilding to finance
Fangda Carbon New Material Co., an integrated carbon materials producer in in the People’s Republic of China with diversified product offerings, including graphite electrodes, carbon blocks, isostatic graphite and iron ore concentrates, sold 22m
The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million. The
